Mark Olsen to Aged, 80 and over
This is a "connection" page, showing publications Mark Olsen has written about Aged, 80 and over.
Connection Strength
0.017
-
Randomized phase II trial of sunitinib on an intermittent versus continuous dosing schedule as first-line therapy for advanced renal cell carcinoma. J Clin Oncol. 2012 Apr 20; 30(12):1371-7.
Score: 0.017